slug: adarx-pharmaceuticals
provider: ADARx Pharmaceuticals
generated_by: planning/capability-mapping/scripts/classify_capabilities.py
model: claude-opus-5
frame:
- Pharmaceuticals & Life Sciences
min_confidence: 0.7
capability_model:
  source: https://github.com/vincentmakes/turbo-ea-capabilities
  license: CC-BY-4.0
  attribution: Turbo EA Capabilities by Vincent Verdet — Turbo EA, https://github.com/vincentmakes/turbo-ea-capabilities,
    CC BY 4.0
  notice: NOTICE
edge_count: 1
edges:
- tag: clinics
  spec_file: adarx-pharmaceuticals-clinics-api-openapi.yml
  capability_id: BC-1520.20
  capability_id_l1: BC-1520
  capability_name: Clinical Trial Site Management
  confidence: 0.7
  evidence: GET /wp/v2/clinic  listTrialClinics  List STOP-HAE trial sites
  reason: The custom post type `clinic` holds 50 published trial-site records for ADARx's Phase 3 STOP-HAE
    study, exposed as a site directory on the patient-recruitment website. That is clinical trial site
    information, closest to Clinical Trial Site Management; the recruitment-facing purpose introduces
    some ambiguity with subject management, hence 0.7.